首页> 外文期刊>ABCD. Arquivos Brasileiros de Cirurgia Digestiva (So Paulo) >ATORVASTATIN CAN PREVENT HEPATIC REMOTE REPERFUSION INJURY
【24h】

ATORVASTATIN CAN PREVENT HEPATIC REMOTE REPERFUSION INJURY

机译:阿托伐他汀可以预防肝脏远程再灌注损伤

获取原文
       

摘要

ABSTRACT Background: Some studies have shown that statins have a promising effect on protection against reperfusion injury. Aim: To evaluate the ability of ischemic postconditioning, statins and both associated to prevent or minimize reperfusion injury in the liver of rats subjected to ischemia and reperfusion by abdominal aorta clamping. Method: Were used 41 Wistar rats, which were distributed into five groups: ischemia and reperfusion (I/R), ischemic postcondictioning (IPC), postconditioning + statin (IPC+S), statin (S) and Sham. It was performed a medium laparotomy, dissection and isolation of the infra-renal abdominal aorta; excepting Sham group, all the others were submitted to the aorta clamping for 70 min (ischemia) and posterior clamping removing (reperfusion, 70 min). In the IPC and IPC+S groups, postconditioning was performed between the ischemia and reperfusion phases by four cycles of reperfusion and ischemia lasting 30 s each. In IPC+S and S groups, preceding the surgical procedure, administration of 3.4 mg/day of atorvastatin was performed for seven days by gavage. The left hepatic lobe was removed for histological study and euthanasia was performed. Results: The mean hepatic injury was 3 in the I/R group, 1.5 in the IPC group, 1.2 in the IPC+S group, 1.2 in the S group, and 0 in the SHAM group. The I/R group had a higher degree of tissue injury compared to the others in the statistical analysis and there was no difference between the others (p<0.01).
机译:摘要背景:一些研究表明,他汀类药物对再灌注损伤的保护具有有希望的影响。目的:评价缺血性后处理,他汀类药物和两者与预防或最小化患者肝脏肝脏肝脏再灌注损伤的能力,通过腹主动脉夹紧再灌注。方法:使用41只Wistar大鼠,分为五组:缺血和再灌注(I / R),缺血性分区(IPC),后处理+他汀类药物(IPC + S),他汀类药物和假。它进行了培养基剖腹手术,解剖和分离的红外腹部主动脉;除了假手术组外,所有其他除了Alta钳位70分钟(缺血)和后夹紧去除(再灌注,70分钟)。在IPC和IPC + S组中,在缺血和再灌注阶段之间进行后处理,通过四个再灌注和缺血持续30次。在IPC + S和S群中,在手术程序之前,通过饲养进行3天的3000毫克/天的阿托伐他汀的给药。除去左肝叶,用于组织学研究,进行安乐死。结果:平均肝损伤在I / R组中为3,IPC组中1.5次,1.2在IPC + S组中,S组1.2,在假手术组中为0。与其他统计分析中的其他人相比,I / R组的组织损伤具有更高程度的组织损伤,其他组织损伤(P <0.01)之间没有差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号